Ailani Myers Accelerating Innovation in Medicine to Cure Kids with Cancer Act

(a) In general. The President shall designate an officer or employee of the Federal Government, or an office, council, or commission of the executive branch, to coordinate Federal efforts to use advanced technologies, including artificial intelligence, to improve the diagnosis, treatment, and prevention of, and the development of cures for, pediatric cancer. The officer, employee, office, council, or commission so designated shall be known as the Coordinator of AI Innovation (in this Act referred to as the Coordinator).

(b) Notification. Not later than 30 days after making a designation under subsection (a), the President shall notify the appropriate committees of Congress of the designation.

(c) Duties. The Coordinator shall—

(1) coordinate and align the activities of relevant Federal departments and agencies, in support of the purposes specified in subsection (a), including—

(A) the Department of Health and Human Services, and the agencies and offices thereof, including—

(i) the National Institutes of Health;

(ii) the Food and Drug Administration;

(iii) the Centers for Medicare & Medicaid Services;

(iv) the Advanced Research Projects Agency for Health; and

(v) the Office of the National Coordinator for Health Information Technology;

(B) the Department of Defense, including the Defense Health Agency and the Congressionally Directed Medical Research Programs;

(C) the Department of Energy;

(D) the Department of Veterans Affairs;

(E) the National Science Foundation;

(F) the National Institute of Standards and Technology;

(G) the Office of Science and Technology Policy; and

(H) such other Federal departments and agencies as the Coordinator determines appropriate;

(2) facilitate, with respect to the Federal efforts relating to pediatric cancer specified in subsection (a), interagency coordination and collaboration among Federal and non-Federal entities, such as patients, survivors, families, caregivers, researchers, and entities funding research on pediatric cancer;

(3) align Federal data and artificial intelligence policies affecting pediatric cancer research and care;

(4) consult with the Director of the National Cancer Institute on matters affecting the CCDI; and

(5) support the Federal activities that advance the purposes of this Act, including the activities of the CCDI.